PDF herunterladen
Synlett 2005(14): 2187-2190  
DOI: 10.1055/s-2005-871974
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Functionalized Bicyclic Triazoles from Chiral Aziridines

Min Sung Kima, Hyo Jae Yoona, Baeck Kyong Leea, Ji Hyun Kwona, Won Koo Lee*a, Yongeun Kimb, Hyun-Joon Ha*b
a Department of Chemistry and Interdisciplinary Program of Integrated Biotechnology, Sogang University, Seoul 121-742, Korea
Fax: +82(2)7010967; e-Mail: wonkoo@sogang.ac.kr;
b Department of Chemistry, Hankuk University of Foreign Studies, Yongin, Kyunggi-Do 449-719, Korea
Fax: +82(31)3304566; e-Mail: hjha@hufs.ac.kr;
Weitere Informationen

Publikationsverlauf

Received 9 June 2005
Publikationsdatum:
20. Juli 2005 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

Enantiomerically pure 3-substituted-5-amino-4-hydroxy-5,6-dihydro-4H-pyrrolo[1,2-c][1,2,3]triazoles were synthesized efficiently from the sequential reactions including a regioselective ring-opening of 1-aziridine-2-yl-propargylic alcohols by azidotrimethylsilane and the subsequent intramolecular 1,3-dipolar cycloaddition between alkyne and azide.

Key words

aziridine - triazole - cycloaddition - alkyne - azide

    References

  • 1 Im C. Maiti SN. Micetich RG. Daneshtalab M. Atchison K. Phillips OA. J. Antibiot.  1994,  47:  1030 
    Google Scholar
  • 2 Velazquez S. Alvarez R. Perez C. Gago F. De C. Balzarini J. Camaraza M. J. Antivir. Chem. Chemother.  1998,  9:  481 
    Google Scholar
  • 3a Genin MJ. Allwine DA. Anderson DJ. Barbachyn MR. Emmert DE. Garmon SA. Graber DR. Grega KC. Hester JB. Hutchinson DK. Morris J. Reischer RJ. Ford CW. Zurenko GE. Hamel JC. Schaadt RD. Stapert D. Yagi BH. J. Med. Chem.  2000,  43:  953 
    CrossrefGoogle Scholar
  • 3b Tomasz A. N. Engl. J. Med.  1994,  330:  1247 
    CrossrefGoogle Scholar
  • 4 Palhagen S. Canger R. Henriksen O. Van Parys JA. Riviere ME. Karolchyk MA. Epilepsy Res.  2001,  43:  115 
    CrossrefGoogle Scholar
  • 5 Gouault N. Cupif JF. Sauleu A. David M. Tetrahedron Lett.  2000,  41:  7293 
    CrossrefGoogle Scholar
  • 6 Mukai C. Kobayashi M. Kubota S. Takahashi Y. Kitagaki S. J. Org. Chem.  2004,  69:  2128 
    CrossrefGoogle Scholar
  • 7 Contelles JM. Fernandez MR. J. Med. Chem.  2000,  43:  953 
    CrossrefGoogle Scholar
  • 8 Bertelli L. Biagi G. Giorgi I. Livi O. Manera C. Scartoni V. Lucacchini A. Giannaccini G. Barili PL. J. Med. Chem.  2000,  35:  333 
    Google Scholar
  • 9 Raghavendra MS. Lam Y. Tetrahedron Lett.  2004,  45:  6129 
    CrossrefGoogle Scholar
  • 10 Lee WK. Ha H.-J. Aldrichimica Acta  2003,  36:  57 
    Google Scholar
  • 11 Yun JM. Shim TB. Hahm HS. Lee WK. Ha H.-J. J. Org. Chem.  2003,  68:  7675 
    CrossrefGoogle Scholar
  • 12 The same product, (1S,2R)-1-aziridine-2-yl-propargylic alcohol (3), could be obtained from addition reactions of the aziridine-(2S)-carboxaldehyde with the corresponding organolithium reagents to afford aziridine-(2S)-propargylic alcohols. The chelation controlled reduction of the carbonyl group of 2-acylaziridine as shown in Scheme 1 provided better stereoselectivity than the addition of organolithium reagents to the aziridine-(2S)-carboxaldehyde. See: Park CS. Choi HG. Lee HJ. Lee WK. Ha H.-J. Tetrahedron: Asymmetry  2000,  11:  3283 
    CrossrefGoogle Scholar
  • 13 Kim BC. Lee WK. Tetrahedron  1996,  52:  12117 
    CrossrefGoogle Scholar
  • 14 Shin S.-H. Han EY. Lee WK. Ha H.-J. Tetrahedron: Asymmetry  2000,  11:  3293 
    CrossrefGoogle Scholar
  • 16a Guerin DJ. Miller SJ. J. Am. Chem. Soc.  2002,  124:  2134 
    CrossrefGoogle Scholar
  • 16b Broggini G. Molteni G. Zecchi G. Synthesis  1995,  6:  647 
    CrossrefGoogle Scholar
  • 16c Broggini G. Garanti L. Molteni G. Zecchi G. J. Chem. Res., Synop.  1997,  10:  380 
    CrossrefGoogle Scholar
  • 16d Pearson WH. Bergmeier SC. Degan S. Lin KC. Poon YF. Schkeryantz JM. Williams JP. J. Org. Chem.  1990,  55:  5719 
    CrossrefGoogle Scholar
  • 16e Marco-Contelles J. Rodriguez-Fernandez M. J. Org. Chem.  2001,  66:  3717 
    CrossrefGoogle Scholar
  • 16f Krulle TM. de la Fuente C. Pickering L. Alpin RT. Tsitanou KE. Zographos SE. Oikonomakos NG. Nash RJ. Griffith RC. Fleet GWJ. Tetrahedron: Asymmetry  1997,  8:  3807 
    CrossrefGoogle Scholar
  • 17 Park CS. Kim MS. Sim TB. Pyun DK. Lee CH. Choi DO. Lee WK. Ha H.-J. J. Org. Chem.  2003,  68:  43 
    CrossrefGoogle Scholar
15

Preparation of (4 S ,5 S )-4-Hydroxy-3-phenyl-5-{(1 R )-1-phenylethylamino)-5,6-dihydro-4 H -pyrrolo[1,2- c ][1,2,3]triazole(5a).
To a solution of aziridine-(2S)-propargyl alcohol (3a, 110 mg, 0.40 mmol) in 2.00 mL of CH2Cl2 under nitrogen atmosphere was added TMSN3 at r.t. The mixture was stirred for 3 h at r.t. then quenched with 6 N HCl. The aqueous layer was extracted with CH2Cl2. The combined extracts were dried over MgSO4, and the solvent was evaporated to give product as yellow oil. The crude reaction product was dissolved in 2.10 mL of DMF at r.t. The mixture was stirred under a nitrogen atmosphere for 16 h at 130 °C. The solvent was evaporated to give the crude product as a yellow oil which was purified by silica gel flash chromatography with 50% EtOAc-hexane to give 106 mg of 5a as a white solid in 83% yield; mp 128-129 °C; [α]D 24 = +38.2 (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 7.82 (d, J = 7.4 Hz, 2 H), 7.37-7.25 (m, 8 H), 4.78 (d, J = 5.6 Hz, 1 H), 4.51 (dd, J = 11.6, 6.9 Hz, 1 H), 4.10 (dd, J = 11.5, 6.8 Hz, 1 H), 4.01 (q, J = 6.4 Hz, 1 H), 3.92 (td, J = 6.9, 5.6 Hz, 1 H), 1.46 (d, J = 6.4 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ = 144.0, 142.3, 138.1, 130.4, 129.1, 128.9, 128.2, 128.0, 126.9, 126.2, 64.5, 62.9, 57.2, 51.1, 24.3. Anal. Calcd for C19H20N4O: C, 71.2; H, 6.29; N, 17.5. Found: C, 71.3; H, 6.30; N, 17.2.

18

Removal of α-Methylbenzyl Nitrogen Protecting Group from 5a.
To a solution of phenylethylamino bicyclic triazole (5a, 110 mg, 0.34 mmol) in 1.90 mL of MeOH was added Pd(OH)2 at r.t. The mixture was stirred for 30 h under 120 psi of H2 (g)at r.t. then the catalyst was filtered and washed with MeOH. The solvent was evaporated to give product as yellow oil which was purified by recrystallization from CH2Cl2 to give 61 mg (84%) of 3-phenyl-5-amino-4-hydroxy-5,6-dihydro-4H-pyrrolo[1,2-c][1,2,3]triazole(9a) as a white solid; mp 197-198 °C; [α]D 24 = +106.5 (c 0.7, CH3OH). 1H NMR (500 MHz, CDCl3): δ = 7.82 (d, J = 8.0 Hz, 2 H), 7.38 (t, J = 7.3 Hz, 2 H), 7.28 (t, J = 7.5 Hz, 1 H), 5.03 (d, J = 5.5 Hz, 1 H), 4.55 (dd, J = 11.1, 7.4 Hz, 1 H), 4.14 (td, J = 7.4, 5.6 Hz, 1 H), 3.96 (dd, J = 11.1, 7.3 Hz, 1 H). 13C NMR (125 MHz, CDCl3): δ = 141.6, 139.3, 130.6, 128.8, 128.2, 125.9, 65.4, 58.6, 51.7. Anal. Calcd for C11H12N4O: C, 61.1; H, 5.59; N, 25.9. Found: C, 61.2; H, 5.53; N, 26.0.